IgG4 breaking the rules
Open accessThe DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Abstract
Summary: Immunoglobulin G4 (IgG4) antibodies have been known for some time to be functionally monovalent. Recently, the structural basis for this monovalency has been elucidated: the in vivo exchange of IgG half‐molecules (one H‐plus one L‐chain) among IgG4. This process results in bispecific antibodies that in most situations will behave as functionally monovalent antibodies. The structural basis for the abnormal behaviour of IgG4 seems to be largely the result of a single amino acid change relative to human IgG1: the change of a proline in core hinge of IgG1 to serine. This results in a marked shift in the equilibrium between interchain disulphide bridges and intrachain disulphide bridges, which for IgG4 results in 25–75% absence of a covalent interaction between the H‐chains. Because of strong non‐covalent interactions between the CH3 domains (and possibly also between the CH1 domain and the trans‐CH2 domain) IgG4 is a stable four‐chain molecule and does not easily exchange half‐molecules under standard physiological conditions in vitro. We postulate that the exchange is catalysed in vivo by protein disulphide isomerase (PDI) and/or FcRn (the major histocompatibility complex (MHC)‐related Fc receptor) during transit of IgG4 in the endosomal pathway in endothelial cells. Because IgG4 is predominantly expressed under conditions of chronic antigen exposure, the biological relevance of this exchange of half‐molecules is that it generates antibodies that are unable to form large immune complexes and therefore have a low potential for inducing immune inflammation. In contrast to monovalent immunoglobulin fragments, these scrambled immunoglobulins have a normal half‐life. The significance of the ensuing bispecificity needs further evaluation, because this will be relevant only in situations where high IgG4 responses are found to two unrelated antigens that happen to be present in the body at the same time and place. In this context the significance of IgG4 autoreactivity might have to be re‐evaluated. The main function of IgG4, however, is presumably to interfere with immune inflammation induced by complement‐fixing antibodies, or, in the case of helminth infection or allergy, by IgE antibodies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Protein Structure Comparison by Alignment of Distance Matrices
Holm, L., & Sander, C. (1993) · Journal of Molecular Biology · doi:10.1006/jmbi.1993.1489 · Cited by 3,984
Anatomy of the antibody molecule
Padlan, E. A. (1994) · Molecular Immunology · doi:10.1016/0161-5890(94)90001-9 · Cited by 896
Aalberse, R. C., van der Gaag, R., & van Leeuwen, J. (1983) · The Journal of Immunology · doi:10.4049/jimmunol.130.2.722 · Cited by 736
Self-citationStructural biology of allergens
Aalberse, R. C. (2000) · Journal of Allergy and Clinical Immunology · doi:10.1067/mai.2000.108434 · Cited by 671
Self-citationHuman IgE, IgG4 and resistance to reinfection with Schistosoma haematobium
Hagan, P., Blumenthal, U. J., Dunn, D., Simpson, A. J. G., & Wilkins, H. A. (1991) · Nature · doi:10.1038/349243a0 · Cited by 648
Multiple Roles for the Major Histocompatibility Complex Class I– Related Receptor FcRn
Ghetie, V., & Ward, E. S. (2000) · Annual Review of Immunology · doi:10.1146/annurev.immunol.18.1.739 · Cited by 474
van Neerven, R. J. J., Wikborg, T., Lund, G., Jacobsen, B., Brinch-Nielsen, A., Arnved, J., & Ipsen, H. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.5.2944 · Cited by 384
Mudde, G. C., van Reijsen, F. C., Boland, G. J., GAST, G. C. D., Bruijnzeel, P. L. B., & Bruijnzeel-Koomen, C. A. F. M. (1990) · PubMed Central · Cited by 291
Dangl, J. L., Wensel, T. G., Morrison, S. L., Stryer, L., Herzenberg, L. A., & Oi, V. T. (1988) · The EMBO Journal · doi:10.1002/j.1460-2075.1988.tb03037.x · Cited by 282
MAKING AND BREAKING DISULFIDE BONDS
Raina, S., & Missiakas, D. (1997) · Annual Review of Microbiology · doi:10.1146/annurev.micro.51.1.179 · Cited by 263
The CXXC Motif: A Rheostat in the Active Site
Chivers, P. T., Prehoda, K. E., & Raines, R. T. (1997) · Biochemistry · doi:10.1021/bi9628580 · Cited by 255
Flexibility of human IgG subclasses
Roux, K. H., Strelets, L., & Michaelsen, T. E. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.159.7.3372 · Cited by 254
A single amino acid substitution abolishes the heterogeneity of chimeric mouse/human (IgG4) antibody
Angal, S., King, D. J., Bodmer, M. W., Turner, A., Lawson, A. D. G., Roberts, G., Pedley, B., & Adair, J. R. (1993) · Molecular Immunology · doi:10.1016/0161-5890(93)90432-b · Cited by 245
Bernstein, I. L., & Ww, S. (1995) · PubMed · Cited by 245
Corper, A. L., Sohi, M. K., Bonagura, V. R., Steinitz, M., Jefferis, R., Feinstein, A., Beale, D., Taussig, M. J., & Sutton, B. J. (1997) · Nature Structural & Molecular Biology · doi:10.1038/nsb0597-374 · Cited by 224
Serum-IgE-facilitated allergen presentation in atopic disease
van der Heijden, F. L., Joost van Neerven, R. J., van Katwijk, M., Bos, J. D., & Kapsenberg, M. L. (1993) · The Journal of Immunology · doi:10.4049/jimmunol.150.8.3643 · Cited by 224
Inhibition of complement activation by IgG4 antibodies.
van der Zee, J. S., van Swieten, P., & Aalberse, R. C. (1986) · PubMed · Cited by 223
Self-citationHussain, R., Poindexter, R. W., & Ottesen, E. A. (1992) · The Journal of Immunology · doi:10.4049/jimmunol.148.9.2731 · Cited by 219
Junghans, R. P. (1997) · Immunologic Research · doi:10.1007/bf02786322 · Cited by 205
Kurniawan, A., Yazdanbakhsh, M., van Ree, R., Aalberse, R., Selkirk, M. E., Partono, F., & Maizels, R. M. (1993) · The Journal of Immunology · doi:10.4049/jimmunol.150.9.3941 · Cited by 193
Self-citationvan der Zee, J. S., van Swieten, P., & Aalberse, R. C. (1986) · The Journal of Immunology · doi:10.4049/jimmunol.137.11.3566 · Cited by 184
Self-citationThe inter-heavy chain disulfide bonds of IgG4 are in equilibrium with intra-chain disulfide bonds
Schuurman, J., Perdok, G. J., Gorter, A. D., & Aalberse, R. C. (2001) · Molecular Immunology · doi:10.1016/s0161-5890(01)00050-5 · Cited by 174
Self-citationAllergen‐specific IgG4 in atopic disease
Aalberse, R. C., Van Milligen, F., Tan, K. Y., & Stapel, S. O. (1993) · Allergy · doi:10.1111/j.1398-9995.1993.tb00749.x · Cited by 164
Self-citationGuddat, L. W., Bardwell, J. C., & Martin, J. L. (1998) · Structure · doi:10.1016/s0969-2126(98)00077-x · Cited by 159
Normal human immunoglobulin G4 is bispecific: it has two different antigen‐combining sites
Schuurman, J., Van Ree, R., Perdok, G. J., Van Doorn, H. R., Tan, K. Y., & Aalberse, R. C. (1999) · Immunology · doi:10.1046/j.1365-2567.1999.00845.x · Cited by 148
Self-citationSubclass Typing of IgG Antibodies Formed by Grass Pollen-Allergic Patients during Immunotherapy
van der Giessen, M., Homan, W. L., van Kernebeek, G., Aalberse, R. C., & Dieges, P. H. (2009) · International Archives of Allergy and Applied Immunology · doi:10.1159/000231566 · Cited by 140
Self-citationIntrachain disulfide bond in the core hinge region of human IgG4
Bloom, J. W., Madanat, M. S., Marriott, D., Wong, T., & Chan, S. K. (1997) · Protein Science · doi:10.1002/pro.5560060217 · Cited by 130
Presence of closely spaced protein thiols on the surface of mammalian cells
Donoghue, N., Yam, P. T., Jiang, X., & Hogg, P. J. (2000) · Protein Science · doi:10.1110/ps.9.12.2436 · Cited by 130
Tan, L. K., Shopes, R. J., Oi, V. T., & Morrison, S. L. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.1.162 · Cited by 128
Burgess, J. K., Hotchkiss, K. A., Suter, C. M., Dudman, N. P. B., Szöllõsi, J., Chesterman, C. N., Chong, B. H., & Hogg, P. J. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.13.9758 · Cited by 128
Aalberse, R. C., Dieges, P. H., Knul-Bretlova, V., Vooren, P. H., Aalbers, M., & van Leeuwen, J. (1983) · Clinical Reviews in Allergy · doi:10.1007/bf02991163 · Cited by 122
Self-citationColcher, D. M., Milenic, D. E., Roselli, M., Raubitschek, A. A., Yarranton, G. T., Griffiths-King, D., Adair, J. R., Whittle, N., Bodmer, M., & Schlom, J. (1989) · PubMed · Cited by 116
Gregory, L. G., DAVIS, K., Sheth, B., Boyd, J. W., Jefferis, R., Nave, C., & Burton, D. R. (1987) · Molecular Immunology · doi:10.1016/0161-5890(87)90184-2 · Cited by 90
Rihet, P., Demeure, C. E., Dessein, A. J. J., & Bourgois, A. (1992) · European Journal of Immunology · doi:10.1002/eji.1830220816 · Cited by 89
King, D. J., Adair, J. R., Angal, S., Low, D. C., Proudfoot, K. A., Lloyd, J. C., Bodmer, M., & Yarranton, G. T. (1992) · Biochemical Journal · doi:10.1042/bj2810317 · Cited by 78
Petersen, J. G. L., & Dorrington, K. J. (1974) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(20)79774-7 · Cited by 74
Contribution of Domain Interface Residues to the Stability of Antibody CH3 Domain Homodimers
Dall’Acqua, W. F., Simon, A. L., Mulkerrin, M. G., & Carter, P. M. (1998) · Biochemistry · doi:10.1021/bi980270i · Cited by 60
IgE‐mediated antigen presentation
Mudde, G. C., Bheekha, R., & Bruijnzeel-Koomen, C. A. F. M. (1995) · Allergy · doi:10.1111/j.1398-9995.1995.tb01132.x · Cited by 47
The enzymic degradation of porphyran
Turvey, J. R., & Christison, J. K. (1967) · Biochemical Journal · doi:10.1042/bj1050317 · Cited by 33
(1995) · Journal of Allergy and Clinical Immunology · doi:10.1016/s0091-6749(95)70167-2 · Cited by 24
Detection of IgG Subclasses with Anti-lgE Activity in Patients with Atopic Diseases
Carini, C., & Fratazzi, C. (2009) · International Archives of Allergy and Immunology · doi:10.1159/000236189 · Cited by 11
Wünsch, E., Moroder, L., GÖHRING‐ROMANI, S., Musiol, H. ‐., Göhring, W., & Scharf, R. (1991) · International journal of peptide & protein research · doi:10.1111/j.1399-3011.1991.tb00734.x · Cited by 8
Cited by
IgG Subclasses and Allotypes: From Structure to Effector Functions
Vidarsson, G., Dekkers, G., & Rispens, T. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00520 · Cited by 2,667
“Conversely, the binding of C1q to IgG4 can be influenced by shielding of the potential binding site by Fab arms (74, 136, 139, 140).”
BackgroundStone, J. H., Zen, Y., & Deshpande, V. (2012) · New England Journal of Medicine · doi:10.1056/nejmra1104650 · Cited by 2,616
Lebrikizumab Treatment in Adults with Asthma
Corren, J., Lemanske, R. F., Hanania, N. A., Korenblat, P. E., Parsey, M. V., Arron, J. R., Harris, J. M., Scheerens, H., Wu, L. C., Su, Z., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1106469 · Cited by 1,514
Kamisawa, T., Zen, Y., Pillai, S., & Stone, J. H. (2015) · The Lancet · doi:10.1016/s0140-6736(14)60720-0 · Cited by 1,212
Anti-Inflammatory Activity of Human IgG4 Antibodies by Dynamic Fab Arm Exchange
van der Neut Kolfschoten, M., Schuurman, J., Losen, M., Bleeker, W. K., Martínez-Martínez, P., Vermeulen, E., den Bleker, T. H., Wiegman, L., Vink, T., Aarden, L. A., et al. (2007) · Science · doi:10.1126/science.1144603 · Cited by 975
Self-citation
Metadata
- Authors
- Aalberse, R. C., & Schuurman, J.
- Venue
- Immunology
- Publisher
- Wiley
- Published
- 2002-01
- Volume
- 105
- Issue
- 1
- Pages
- 9-19
- ISSN
- 0019-2805 (ISSN-L)
- 1365-2567
- OpenAlex
- W2050656150
- Cited by
- 449
- References
- 43
- FWCI
- 4.98
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.